15th International Thyroid Congress
| Browse by: | Sort by: |
15th ITC Opening Session – Progress in Thyroid Research: Highlights from the Last Decade
Autoimmunity
Sandra M. McLachlan, PhD
Cedars-Sinai Medical Center, Los Angeles, CA
Free
All slides withheld
15th ITC Opening Session – Progress in Thyroid Research: Highlights from the Last Decade
Thyroid Cancer Neoplasm
Martin Schlumberger, MD
Institute Gustave-Roussy, Villejuif 94805 Cedex, France
Free
Slides + audio
15th ITC Opening Session – Progress in Thyroid Research: Highlights from the Last Decade
Clinical Thyroidology
David S. Cooper
Johns Hopkins University School of Medicine, Baltimore, MD
Free
Slides + audio
Early Riser Symposium: New Modalities in the Treatment of Medullary Thyroid Cancer (MTC)
Targeted Therapeutic Agents for MTC
Rossella Elisei, MD
University of Pisa, Pisa 56124, Italy
Free
Slides + audio
Early Riser Symposium: New Modalities in the Treatment of Medullary Thyroid Cancer (MTC)
Update on MTC Guidelines
Samuel A. Wells, Jr., MD
National Cancer Institute NIH, Bethesda, MD
Free
Slides + audio
Opening Plenary Session: Advancing Individualized Medicine with Public–Private Partnerships
Symposium: New Concepts in the Management of Thyroid Nodules
Epidemiology of Benign Thyroid Nodules
Shuhang Xu, MD
Nanjing University of Traditional Chinese Medicine, Nanjing, Peoples Republic of China
Free
Slides + audio
Symposium: Nontraditional TSHR Signaling
Selective TSHR Signaling by TSHR Antibodies
Terry F. Davies, MD, FRCP
Mount Sinai School of Medicine, New York, NY
Free
Slides + audio
Symposium: TR Alpha Mutations – Bench to Bedside
Human Mutations
Carla Moran, MB, ChB
University of Cambridge, Cambridge, United Kingdom
Free
Slides + audio
Symposium: TR Alpha Mutations – Bench to Bedside
Treatment of Patients
Robin P. Peeters, MD, PhD
Erasmus MC, Rotterdam, Rotterdam, Netherlands
Free
Slides + audio
Symposium: Thyroid Cancer – Translating Basic Science Discoveries to the Clinic
Redifferentiation of RAI–Refractory Thyroid Cancer
James A. Fagin, MD
Memorial Sloan-Kettering Cancer Center, New York, NY
Free
Slides + audio
Symposium: Thyroid Cancer – Translating Basic Science Discoveries to the Clinic
Targeted Therapy
Sophie Leboulleux, MD, PhD
Service De Medecine Nucleair Et De Cancerologie Endocrinienne Institut, Villejuif, France
Free
Slides + audio
DD1 – Discussion/Debates Clinical: A Case-Based Discussion of International Hypothyroidism Guidelines
Jacqueline Jonklaas, MD
Georgetown University Medical Center, Washington, DC
Free
Slides + audio
DD2 – Discussion/Debates Clinical: Targeted Therapy for Thyroid Cancer: When and What?
Steven I. Sherman, MD
The University of Texas M. D. Anderson Cancer Center, Houston, TX
Free
Slides + audio
DD2 – Discussion/Debates Clinical: Targeted Therapy for Thyroid Cancer: When and What?
Johannes W.A. Smit, MD, PhD, FRCP
Radboud University Medical Center, Nijmegen, Netherlands
Free
All slides withheld
DD5 – Discussion/Debates Clinical: Is There a Role for Long-Term Anti-Thyroid Drug Therapy?
Douglas S. Ross, MD
Massachusetts General Hospital, Boston, MA
Free
Slides + audio
DD5 – Discussion/Debates Clinical: Is There a Role for Long-Term Anti-Thyroid Drug Therapy?
Stig Andersen, MD, PhD, PGCME
Aalborg University Hospital, Aalborg, Denmark
Free
All slides withheld
Symposium: Clinical Utility of Anti–Thyroid Antibody Measurements
Pregnancy
Alex S. Stagnaro-Green, MD, MHPE
University of Illinois College of Medicine At Rockford, Rockford, IL
Free
Slides + audio
Symposium: Clinical Utility of Anti–Thyroid Antibody Measurements
Hashimoto's Thyroiditis
Mario Rotondi
University of Pavi, Italy
Free
Slides + audio
Symposium: Clinical Utility of Anti–Thyroid Antibody Measurements
Graves' Disease
Eijun Nishihara, MD
Kuma Hospital, Kobe 8-2-35, Japan
Free
Slides + audio
Symposium: Prognostic Assessment of Thyroid Cancer
Clinical Risk Stratification
Furio Pacini
University of Siena, Siena 53100, Italy
Free
Slides + audio
Symposium: Prognostic Assessment of Thyroid Cancer
Real Time Prognostication
R. Michael Tuttle, MD
Memorial Sloan-Kettering Cancer Center, New York, NY
Free
Slides + audio
Symposium: T4/T3 Combination Therapy for Hypothyroidism
Do Patients Prefer T4/T3 Therapy, and Why?
Colin M. Dayan, MA, MBBS, FRCP, PhD
Cardiff University School of Medicine, Cardiff, United Kingdom
Free
Slides + audio
Symposium: T4/T3 Combination Therapy for Hypothyroidism
What is the Mechanism for Enhanced Weight Loss with T3?
Francesco S. Celi, MD
Virginia Commonwealth University, Richmond, VA
Free
Slides + audio
Symposium: T4/T3 Combination Therapy for Hypothyroidism
Risks/Safety of Combination Therapy
Anne R. Cappola, MD, ScM
University of Pennsylvania School of Medicine, Philadelphia, PA
Free
All slides withheld
